nivolumab
bms
['nadim', 'check,mate,816']
nadim 2 results are in line with nadim-1 &amp; checkmate-816. cementing neoadjuvant io as the standard of care. #asco2022 
Professor, Head and Neck-Medical Oncologist, Neuro-Medical Oncologist, Thoracic-Medical Oncologist,Researcher,Immunotherapy, Statistics and Phase 1/2/3 studies